Raka Jati Prasetya
Anaesthesiology and Intensive Therapy Consultant, Departement of Anaesthesiology and Intensive Therapy, Faculty of Medicine, University of North Sumatera, Indonesia

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

What is The Effect of Early Enteral Nutrition on Mortality in Critically Ill Patients Receiving Vasopressor Support? : A Systematic Review Landong Sijabat; Raka Jati Prasetya; Mutia Juliana
The International Journal of Medical Science and Health Research Vol. 40 No. 2 (2026): The International Journal of Medical Science and Health Research
Publisher : International Medical Journal Corp. Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70070/8e740g61

Abstract

Background: The effect of early enteral nutrition (EEN) on mortality in critically ill patients requiring vasopressor support remains debated due to conflicting trial results. Methods: This systematic review synthesized data from 80 studies (2003-2025), including landmark RCTs (NUTRIREA-2, NUTRIREA-3) and large observational cohorts, focusing on mortality, vasopressor dose-response, enteral tolerance, and safety. Results: EEN did not reduce 28-day or 90-day mortality in patients with severe shock (norepinephrine ≥0.3 µg/kg/min) in major RCTs [1,2]. However, a clear dose-response relationship was identified: EEN significantly reduced mortality at low (<0.1 µg/kg/min) and medium (0.1-0.3 µg/kg/min) norepinephrine doses but not at high doses (≥0.3 µg/kg/min) [3]. Benefits were seen in transient shock (resolving <24h) but not persistent shock [4]. High-calorie EEN increased gastrointestinal complications, including vomiting (HR 1.89) and bowel ischemia (HR 3.84) [1], while low-calorie feeding (6 kcal/kg/day) reduced these risks [2]. Discussion: The effect of EEN on mortality is highly context-dependent. The lack of benefit in trials like NUTRIREA-2/3 is explained by enrollment of patients on high-dose vasopressors and use of immediate full-dose feeding—a strategy now considered harmful. Observational benefits likely reflect hemodynamic stability at feeding initiation. A safe approach includes starting trophic EEN (6-15 kcal/kg/day) after initial resuscitation when vasopressor doses are stable and ≤0.3 µg/kg/min, with gradual advancement. Conclusion: EEN does not reduce mortality in patients on high-dose vasopressors (≥0.3 µg/kg/min norepinephrine) but may improve survival in those on low-to-moderate doses with transient shock. Clinical practice should shift from rigid timing to hemodynamic-guided, gradual feeding.
What is The Effect of Early Surgical Stabilization of Rib Fractures Compared to Conservative Management on Pain Control and Pulmonary Function in ICU Patients? : A Systematic Review Landong Sijabat; Raka Jati Prasetya; Mutia Juliana
The International Journal of Medical Science and Health Research Vol. 40 No. 2 (2026): The International Journal of Medical Science and Health Research
Publisher : International Medical Journal Corp. Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70070/zb5qvt71

Abstract

Introduction: Rib fractures, especially flail chest and multiple displaced fractures, cause severe pain and respiratory dysfunction, often requiring ICU admission. The optimal management—early surgical stabilization (SSRF) versus conservative treatment—remains debated. Methods: This systematic review synthesized 80 studies (RCTs, etc) comparing early SSRF (≤72 hours) to conservative management in adult ICU patients with rib fractures. Outcomes focused on pain control, pulmonary function, and clinical endpoints. Results: Early SSRF significantly reduced pain scores at 2 weeks (NPS 2.9 vs. 4.5, p<0.01) [1] and lowered opioid requirements (155 vs. 246 morphine milliequivalents, p<0.001) [3]. Pulmonary benefits included shorter mechanical ventilation (mean difference -4.52 days) [4], reduced pneumonia (RR 0.57) [11], and fewer tracheostomies (OR 0.25) [4]. ICU stay decreased by ~4 days [8], and mortality improved (OR 0.3) [8]. Early intervention (≤72h) was superior to delayed surgery [21,25]. Benefits were most pronounced in flail chest, elderly, and mechanically ventilated patients [13,14,43]. Discussion: SSRF provides rapid pain relief, improves respiratory mechanics, and reduces complications, but outcomes depend on timing, patient selection, and injury pattern. Heterogeneity exists, with non-flail fractures showing less consistent benefit [19]. Conclusion: Early SSRF (within 72 hours) significantly improves pain, pulmonary function, and survival in high-risk ICU patients with severe rib fractures. Delayed surgery loses advantage. Future RCTs should standardize timing and subgroups.